A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-MASKED STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF SHP640 (PVP-IODINE 0.6% AND DEXAMETHASONE 0.1%) OPHTHALMIC SUSPENSION COMPARED TO PLACEBO IN THE TREATMENT OF BACTERIAL CONJUNCTIVITIS.

计划入组 0 人

Respiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd.

计划入组 211 人 · 首次发布于 2023 年 5 月 17 日

The Purpose of This Clinical Trial is to Evaluate the Accuracy of Blood Pressure Measurement of HiCardi M350 Compared to Blood Pressure Measured by Auscultatory Sphygmomanometer in Adult Volunteers (Including Those Meeting Blood Pressure Distribution Requirements) in Accordance With ISO 81060-2:2018

计划入组 100 人 · 首次发布于 2026 年 6 月 3 日

HiCAR-T

H102

G100

PICARDI MARCO

Italy

Pharma 2100 ApS

Denmark

Micardia Corporation

United States

Dong-A ST's Hicardi+ H100 ECG Monitoring Platform Receives FDA Clearance

Dong-A ST Posts Record Q2 Sales of KRW 207.8 Billion, Operating Profit Surges 170%

Korean Drugmakers Pivot to Digital Healthcare as Generic Price Cuts Squeeze Profitability